Investors are starting off bullish on the largest eye care device company, Alcon. In the first day of trading for the Novartis AG spinoff, in early U.S. trading the company was valued at $28.5 billion. Its share price was about $58 (NYSE:ALC), above the roughly $40 to $50 share price range that had been anticipated. Read More
